Cryopreservation of ovarian tissue as a method for fertility preservation in women

Česká verze

Authors: V. Hončová
Authors place of work: Porodnicko-gynekologická klinika LF UP a FN Olomouc
Published in the journal: Ceska Gynekol 2023; 88(1): 44-51
Category: Přehledový článek
doi: https://doi.org/10.48095/cccg202344

Summary

Objective: To summarize the current possibilities of ovarian tissue cryopreservation as one of the other possible methods for fertility preservation in women. Methods: Literature review obtained from studies and literature related to ovarian tissue cryopreservation. Conclusion: Cryopreservation of ovarian tissue and its subsequent transplantation has a significant potential for preserving fertility not only for prepubertal and oncological patients, but also for patients with various medical indications leading to premature ovarian insufficiency. In order to maintain the best possible quality of oocytes in cryopreserved ovarian tissue, it is necessary to constantly optimize, standardize and compare both cryopreservation protocols, procedures and strategies, as well as the process of thawing ovarian tissue with its subsequent transplantation.

Keywords:

assisted reproduction – In vitro fertilization – oncofertility – vitrification – fertility preservation – cryopreservation of ovarian tissue – slow freezing – in vitro maturation

Zdroje

1. Mardešić T, Jelínková L, Melicharová L. Úspěšná transplantace ovariální tkáně u pacientky s ovariálním selháním po onkologické léčbě. Ceska Gynekol 2017; 82 (1): 38–41.

2. Vuković P, Kasum M, Orešković D et al. Importance of ovarian tissue cryopreservation in fertility preservation and anti-aging treatment. Gynecol Endocrinol 2019; 35 (11): 919–923. doi: 10.1080/09513590.2019.1611763.

3. Sugishita Y, Taylan E, Kawahara T et al. Comparison of open and a novel closed vitrification system with slow freezing for human ovarian tissue cryopreservation. J Assist Reprod Genet 2021; 38 (10): 2723–2733. doi: 10.1007/s10815-021-02297-9.

4. Donnez J, Dolmans MM. Preservation of fertility in females with haematological malignancy. Br J Haematol 2011; 154 (2): 175–184. doi: 10.1111/j.1365-2141.2011.08723.x.

5. Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol 2005; 17 (3): 299–308. doi: 10.1097/01.gco.0000169108.15623.34.

6. Gjeterud J, Kristensen SG, Fedder J. Indications for cryopreservation and autotransplantation of ovarian tissue. Tidsskr Nor Laegeforen 2021; 141 (2021–15). doi: 10.4045/tidsskr.21.0030.

7. Rivas Leonel EC, Lucci CM, Amorim CA. Cryopreservation of human ovarian tissue: a review. Transfus Med Hemother 2019; 46 (3): 173–181. doi: 10.1159/000499054.

8. Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med 2017; 377 (17): 1657–1665. doi: 10.1056/NEJMra1614676.

9. Gellert SE, Pors SE, Kristensen SG et al. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet 2018; 35 (4): 561–570. doi: 10.1007/s10815-018-1144-2.

10. Talwar P, Awasthi P. Ovarian Tissue Cryopreservation. In: Allahbadia GN, Ata B, Lindheim SR et al (eds). Textbook of Assisted Reproduction. Singapore: Springer 2020.

11. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003; 18 (1): 117–121. doi: 10.1093/hum rep/deg016.

12. Huser M. Onkofertilita – nová oblast reprodukční medicíny. 1. vyd. Praha: Mladá fronta 2014.

13. Dolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol 2021; 70: 63–80. doi: 10.1016/ j.bpobgyn.2020.06.011.

14. Yding Andersen C, Mamsen LS, Kristensen SG. Fertility preservation: freezing of ovarian tissue and clinical opportunities. Reproduction 2019; 158 (5): F27–F34. doi: 10.1530/REP-18-0635.

15. Kristensen SG, Andersen CY. Cryopreservation of ovarian tissue: opportunities beyond fertility preservation and a positive view into the future. Front Endocrinol (Lausanne) 2018; 9: 347. doi: 10.3389/fendo.2018.00347.

16. Morewood T, Getreu N, Fuller B et al. The effect of thawing protocols on follicle conservation in human ovarian tissue cryopreservation. Cryo Letters 2017; 38 (2): 137–144.

17. Dolmans MM, Hossay C, Nguyen TY et al. Fertility preservation: how to preserve ovarian function in children, adolescents and adults. J Clin Med 2021; 10 (22): 5247. doi: 10.3390/ jcm10225247.

18. De Roo C, Tilleman K. In vitro maturation of oocytes retrieved from ovarian tissue: outcomes from current approaches and future perspectives. J Clin Med 2021; 10 (20): 4680. doi: 10.3390/jcm10204680.

19. Kedem A, Yerushalmi GM, Brengauz M et al. Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation. J Assist Reprod Genet 2018; 35 (5): 851–856. doi: 10.1007/s10815-018-1153-1.

20. Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril 2014; 101 (5): 1237–1243. doi: 10.1016/j.fertnstert.2014.02.052.

21. Kometas M, Christman GM, Kramer J et al. Methods of ovarian tissue cryopreservation: is vitrification superior to slow freezing? Ovarian tissue freezing methods. Reprod Sci 2021; 28 (12): 3291–3302. doi: 10.1007/s43032-021-00591-6.

22. Suzuki N, Yoshioka N, Takae S et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod 2015; 30 (3): 608–615. doi: 10.1093/humrep/deu353.

23. Oktay K, Buyuk E, Veeck L et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 363 (9412): 837–840. doi: 10.1016/ S0140-6736 (04) 15728-0.

24. Donnez J, Dolmans MM. Natural hormone replacement therapy with a functioning ovary after the menopause: dream or reality? Reprod Biomed Online 2018; 37 (3): 359–366. doi: 10.1016/j.rbmo.2018.05.018.

25. Huser M, Žáková J, Crha I et al. Kryokonzervace ovariální tkáně u onkologických pacientek – 6 let klinických zkušeností. Ceska Gynekol 2012; 77 (2): 118–126.